Resonac Holdings Corporation FY2026 Q1 Earnings Report

Financial Highlights

• Net Sales: ¥307.89B
• Operating Income: ¥22.14B
• Net Income: ¥15.66B
• EPS: ¥84.44

Income Statement

Balance Sheet

Cash Flow Statement

Profitability Ratios

Year-over-Year Comparison

Share Information

Segment Information

Full Year Forecast

---

AI Financial Analysis

Executive Summary

Q1 FY2026 was a clear beat on profitability despite a modest revenue decline. Revenue decreased 4.1% YoY to 307.9bn JPY, while operating income surged 58.4% to 22.1bn JPY and net income attributable to owners rose 74.6% to 15.3bn JPY. Gross margin expanded sharply by 688 bps to 29.9%, driven by a better mix and recovery in Semiconductor & Electronic Materials. Operating margin improved by 284 bps to 7.2% as SG&A discipline (down 5.8bn JPY YoY) and stronger gross profit offset higher other expenses. Net margin improved by 223 bps to 5.0%. The interest burden improved materially (finance costs fell to 3.6bn JPY), yielding interest coverage of 6.1x. Equity-method income contributed 2.9bn JPY, or 12.6% of profit before tax, providing a helpful but not dominant lift. Comprehensive income rebounded to 22.7bn JPY on positive translation effects, boosting accumulated OCI and equity. The balance sheet remains sizable with total assets of 2.11tn JPY and an equity ratio of 33.7%; current ratio stands at a healthy ~1.8x. Short-term borrowings (171.2bn JPY) are comfortably covered by cash (281.9bn JPY) and broader current assets. Segment-wise, Semiconductor & Electronic Materials was the profit engine with 25.2% margin and 73.7% YoY profit growth; Mobility also recovered strongly, while Chemicals and Crasus Chemical remained loss-making but narrowed losses. Against full-year guidance, progress is slightly behind on profits: operating income at 21.1% and net income at 19.9% of plan, implying heavier H2 earnings weighting. The mix shift toward higher-margin semiconductor materials and cost control underpinned the quarter’s outperformance in margins. Non-operating items were net positive but small relative to revenue and EBIT. Intangibles are 19.3% of assets, consistent with an IP-heavy portfolio, and FX tailwinds aided OCI. Forward-looking, sustained strength in semiconductor end-markets and continued loss-narrowing in Chemicals will be key to closing the gap to full-year profit guidance. Near-term risks center on inventory normalization (high inventory days) and execution on underperforming chemical chains, but Q1 results set a constructive starting point for the year.

Profitability Analysis

ROE of 2.1% decomposes into Net Profit Margin (5.0%) × Asset Turnover (0.146) × Financial Leverage (2.86x). The largest YoY change came from the margin component: operating margin rose from 4.35% to 7.19% (+284 bps) and net margin from 2.73% to 4.96% (+223 bps), while leverage and asset turnover were broadly stable at low levels. The business driver was a sharp margin recovery in Semiconductor & Electronic Materials (25.2% segment margin, +73.7% YoY OI) and tighter SG&A control, partially offset by losses in Chemicals and Crasus Chemical. The improvement appears cyclical-structural in semis (mix and pricing/volume normalization) and should be partly sustainable if end-demand holds; loss-narrowing in Chemicals indicates early progress but needs continued execution. SG&A decreased in absolute terms (-5.8bn JPY YoY), but the SG&A ratio rose 60 bps to 19.1% due to lower revenue, a manageable trade-off given gross margin expansion.

Growth Assessment

Top-line contracted 4.1% YoY to 307.9bn JPY due to weakness in Crasus Chemical (olefins) and softness in some chemical chains, offset by 21.1% growth in Semiconductor & Electronic Materials. Operating income grew 58.4% YoY to 22.1bn JPY on a 688 bps gross margin expansion and lower finance costs; net income to owners grew 74.6% to 15.3bn JPY. Growth is currently mix-led and margin-driven rather than volume-driven at the consolidated level. Equity-method income accounted for 2.9bn JPY (12.6% of PBT), providing incremental support. The improved profitability in Mobility and Innovation Enabling Materials suggests broader cyclical recovery beyond semis. Sustaining growth will depend on continued semiconductor cycle strength and further reduction of losses within Chemicals and Crasus Chemical.

Financial Health

Liquidity is solid: current assets 857.8bn JPY vs current liabilities 474.5bn JPY imply a current ratio of ~1.81x. Cash and cash equivalents of 281.9bn JPY exceed short-term borrowings of 171.2bn JPY, limiting near-term refinancing risk. Total bonds and borrowings are 940.8bn JPY against total equity of 738.0bn JPY; the reported D/E ratio is 1.86x, which is elevated but below the 2.0x warning threshold. Interest coverage is strong at ~6.1x (EBIT/finance costs), indicating manageable debt service. Non-current liabilities are sizable (896.9bn JPY) but broadly stable quarter-on-quarter, with deferred tax liabilities down modestly. There is no evident maturity mismatch given robust current assets and cash. Assets held for sale increased to 38.1bn JPY with associated liabilities of 10.5bn JPY, implying ongoing portfolio optimization.

Notable B/S Changes

Cash and cash equivalents: +19.9bn (+7.6%) QoQ – stronger liquidity cushion. Trade receivables: -38.0bn (-13.6%) QoQ – improved collections and/or seasonality supporting working capital. Inventories: +10.5bn (+5.1%) QoQ – builds raise working capital intensity; monitor DIO and obsolescence risk. Property, plant and equipment: +10.6bn (+1.6%) QoQ – ongoing investment supporting capacity and technology roadmap. Deferred tax liabilities: -3.2bn (-4.5%) QoQ – modest reduction supports equity. Accrued expenses: +11.9bn (+28.6%) QoQ – timing of expenses/payables increased current liabilities. Non-current borrowings: -7.5bn (-1.0%) QoQ – slight deleveraging on the long-term debt stack. Accumulated OCI: +7.3bn (+9.6%) QoQ – positive FX translation gains increased equity.

Cash Flow Quality

Operating profit increased despite sizable other expenses (13.2bn JPY) largely offset by strong core profitability in semiconductors and cost controls. Finance costs declined meaningfully, and non-operating contributions were modest relative to revenue and EBIT. Impairment losses were immaterial at 0.2bn JPY. Equity-method income (2.9bn JPY) was supportive but not a dominant earnings driver, indicating improving quality of earnings centered on operations.

Dividend Sustainability

Dividend per share in the data is 0.0, implying a payout ratio of 0% against basic EPS of 84.44 JPY for Q1 and a forecast EPS of 425.45 JPY. With profitability improving and liquidity healthy, capacity to fund future dividends from earnings appears adequate, subject to capex and balance sheet priorities.

Risk Assessment

Business risks include Semiconductor cycle sensitivity: profitability heavily supported by Semiconductor & Electronic Materials (25.2% margin, 43.7% of sales mix)., Chemicals and Crasus Chemical losses: continued underperformance could dilute consolidated margins if normalization stalls., High inventory intensity: 366 DIO elevates obsolescence and write-down risk in volatile end-markets., FX translation volatility: OCI sensitive to currency movements, impacting equity..

Financial risks include Elevated leverage: reported D/E of 1.86x increases sensitivity to credit conditions., Large non-current debt (769.5bn JPY) requires sustained operating cash generation to maintain coverage., Equity-method dependency: 12.6% of PBT from affiliates introduces external performance risk..

Key concerns include ⚠️ CAPITAL_EFFICIENCY: ROIC of 2.1% is below a 5% threshold, indicating low capital productivity despite improved margins., ⚠️ HIGH_INVENTORY_DAYS: DIO at 366 days is far above manufacturing norms, implying elevated working capital lock-up and potential markdown risk., Progress vs guidance: operating income at 21.1% and net income at 19.9% of full-year plan suggests back-half earnings concentration, increasing execution risk..

Investment Implications

Key takeaways include Margin-led earnings recovery: OM +284 bps YoY to 7.2% on semiconductor strength and cost control., Semiconductor & Electronic Materials is the core profit driver (OI 34.0bn JPY; 25.2% margin)., Chemicals and Crasus Chemical losses narrowed but remain a drag; further restructuring and pricing discipline needed., Liquidity is sound (current ratio ~1.8x; cash 281.9bn JPY), and interest coverage improved to ~6.1x., Capital efficiency remains weak (ROE 2.1%; ROIC 2.1%), highlighting the need for higher asset turnover and portfolio optimization., Inventory days at 366 are a key overhang on cash conversion and earnings resilience..

Metrics to watch include Core operating margin in Semiconductor & Electronic Materials and its order momentum., Loss trajectory in Chemicals and Crasus Chemical (quarterly OI and pricing spreads)., Inventory levels and DIO trend; working capital release., Interest coverage and net debt trajectory., Equity-method income run-rate relative to PBT., Progress rate vs guidance each quarter (target ~25/50/75% cadence)..

Regarding relative positioning, Relative to diversified chemical peers, the company is more levered to the semiconductor upcycle, delivering superior near-term margins but carrying higher working capital intensity and weaker capital efficiency; against pure-play semiconductor material peers, profitability is competitive while balance sheet leverage and inventory days are elevated.